// App-Quantinova.ai

12336 : Cangrelor Decreases Ischemia Driven Revascularization in Patients Undergoing Percutaneous Coronary Intervention: Evidence From a Meta-analysis of Randomized Trials

Researchers

Presenter

  • Partha Sardar

Principal Investigators

  • Suarav Chatterjee

  • Savi Mushiyev

  • Gerald Pekler

  • Ferdinand Visco

Medical Centers

  • Metropolitan Hosp Ctr, New York, NY

  • Brown university and the providence VA medical center, providence, RI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Streptase

  • Clopidogrel bisulfate

  • Hydroxyzine

  • Adenosine

  • Adenosine Intravenous

  • cangrelor

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved